Perioral dermatitis
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
A na-ahụkarị papules n'akụkụ ọnụ na imi nwere ụfọdụ ọbara ọbara n'azụ n'ụdị patch ma ọ bụ pustule n'akụkụ ọnụ.
References
Perioral dermatitis bụ ọnọdụ akpụkpọ ahụ na-adịghị mma nke a na-ahụkarị na ụmụ agbọghọ, nke a na-eji obere mkpọ na-acha uhie uhie ma ọ bụ akpụkpọ anụ kpọrọ nkụ nke dị n'akụkụ ọnụ. Ọ bụ ezie na ọ na-emetụtakarị ebe dị n'akụkụ ọnụ, ọ pụkwara ịpụta n'akụkụ anya na imi, na-eduga na aha njirimara ya, periorificial dermatitis. Ojiji nke steroid n'elu ihu nwere ike ịkpalite ọnọdụ a, ya mere nzọụkwụ mbụ na ọgwụgwọ na-akwụsịkarị iji steroid ndị a. Nhọrọ ọgwụgwọ ndị ọzọ gụnyere itinye metronidazole n'elu ma ọ bụ calcineurin inhibitors, ma ọ bụ ịṅụ ọgwụ nje tetracycline ọnụ. Peroral dermatitis na-anabatakarị ọgwụgwọ nke ọma, mana ọ nwere ike ịdịgide mgbe ụfọdụ ma ọ bụ na-alọghachi ugboro ugboro.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common area of distribution, this disease also can affect the periocular and paranasal skin. For this reason, it is often referred to as periorificial dermatitis. Topical steroid use to the face can trigger this, and therefore, a primary recommendation for treatment would be discontinuation of steroid application by the patient. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. Perioral dermatitis often responds readily to therapy but can be chronic and recurrent.
Propolis bụ ihe lipophilic nke a na-amịpụta na osisi site na aṅụ. Ebumnuche nke akụkọ ikpe a bụ iji gosipụta mkpa nke ihe a dị ka ihe kpatara nfụkasị kọntaktị cheilitis. Otu nwanyị dị afọ 21 na-arịa ọrịa nwere mkpesa nke pruritic perioral eczema maka afọ 5. N'ime ọnwa gara aga, ọ na-emetụtakwa olu. Mgbe ọ chọpụtachara kọntaktị dermatitis, e debere ya na ule patch. Nsonaazụ nke ule patch dị ezigbo mma maka propolis (++) .
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Propolis is a lipophilic resin extracted from plants by bees. The purpose of this case report was to show the importance of this substance as cause of allergic contact cheilitis. A 21-year-old female patient complained of pruritic perioral eczema for 5 years. In the past months it also affected the neck. After diagnosing contact dermatitis, she was submitted to a patch test with a Latin American baseline series. The result was strongly positive for propolis (++)
Ọrịa akpụkpọ anụ dị iche iche nke erythematous papules mara. Ọrịa na-ahụkarị ụlọ ọgwụ - folliculitis, rosacea ; Ọrịa na-adịghị ahụkebe - eosinophilic pustular folliculitis (EPF) , granulomatous periorificial dermatitis (GPD) , lupus miliaris disseminatus faciei (LMDF) .
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Various inflammatory skin diseases characterized by erythematous papules that most often affect the face include clinically common folliculitis and rosacea, and relatively rare eosinophilic pustular folliculitis (EPF), granulomatous periorificial dermatitis (GPD), and lupus miliaris disseminatus faciei (LMDF).
Ndị steroid dị n'elu nwere ike ịbụ ihe kpatara ọnọdụ ahụ na mmiri mmiri na ihe ịchọ mma nwekwara ike inye aka na mmepe nke ọrịa anụ ahụ. Ọgwụgwọ na-abụkarị site n'ịkwụsị ọgwụ steroid na ihe ịchọ mma, na n'ọnọdụ ndị ka njọ, na-ewere tetracyclines n'ọnụ. Ịkwụsị steroid nwere ike ime ka ọkụ ọkụ ka njọ na mbụ.
A na-eche na ọnọdụ a ga-emetụta 0.5-1% nke ndị mmadụ kwa afọ na mba ndị mepere emepe. Ihe ruru 90% nke ndị ọ metụtara bụ ụmụ nwanyị nọ n'agbata afọ 16 na 45.
○ Ọgwụgwọ ― OTC Ọgwụ
A na-ebutekarị perioral dermatitis site na kọntaktị dermatitis na-adịghị ala ala nke ihe ịchọ mma, ya mere a naghị atụ aro itinye ihe ịchọ mma n'akụkụ ọnụ. Inweta OTC antihistamine nwere ike inye aka. A na-achọkarị ọgwụgwọ karịa ọtụtụ ọnwa.
#OTC antihistamine